Current Size: 100%


Jan Pencik receives poster prize at first LBG health sciences meeting

The LBG organised a special meeting for all Ludwig Boltzmann Institutes and Clusters, active in the area of medicine and life sciences as well as its related disciplines. The main purpose was to get to know each other’s research, to establish new cooperations under the roof of the LBG and to inform the medical community/public about the health related LBG activities. The common denominator of the participating institutes and clusters is also the namesake of the meeting: Health Sciences

Dr. Moriggl thanks DI Pröll and BM Töchterle for their support

At the recent networking event of the LBG, held on the twentieth floor of the Raiffeisenhaus in Vienna, Dr. Moriggl presented science minister Karlheinz Töchterle and President Josef Pröll with a collection of scientific images. He used the opportunity to show his gratitude to both for their support in extending the LBI-CR for a second funding period and discussed his future plans to maintain momentum for the research institute.

Secret second life of cdk6 in lymphomas

CDK6 is an oncogenic kinase regulating the cell cycle. In CancerCell a research team led by Prof. Veronika Sexl from the Veterinary University Vienna and contributions from the LBI-CR demonstrated that CDK6 performs a kinase-independent transcriptional function in regulating expression of VEGF-Aandp16 INK4a.These observations link the cell cycle machinery and angiogenesis and reveal the presence of a fail-safe antiproliferative mechanism.

Alternative target for breast cancer drugs

Scientists from the Ludwig Boltzmann Institut for Cancer Research have contributed to identify higher levels of a receptor protein found on the surface of human breast tumour cells that may serve as a new drug target for the treatment of breast cancer. The results, which are published in EMBO Molecular Medicine, show that elevated levels of the protein Ret, which is short for “Rearranged during transfection”, are associated with a lower likelihood of survival for breast cancer patients in the years following surgery to remove tumours and cancerous tissue.

LBI-CR holds Annual Meeting 2013 in Obergurgl

Cancer researchers take the hidden activities of tumor cells into their sights

At the annual meeting of the Ludwig Boltzmann Institute for Cancer Research over 40 renowned scientists from Austria, Germany, USA and Switzerland gathered at the university center Obergurgl of the University of Innsbruck on April 16 - 17. They presented and discussed their current work in experimental cancer research. As a general consensus emerged that the interaction of tumor cells with their surrounding cells, the stroma warrants closer attention.